Precision BioSciences has been given Orphan Drug Designation by the U.S. Food and Drug Administration for its new treatment, PBGENE DMD, which is being developed
Ready-to-infuse sepsis therapy marks new advancement in time-critical treatment Hikma Pharmaceuticals, the multinational pharmaceutical company, announced the approval of a novel formulation of the first-of-its-kind,
The FDA has approved an updated label for Vizamyl (flutemetamol F 18 injection), including quantification which enables a more continuous and objective measure of amyloid
Precision BioSciences, a clinical stage gene editing company utilizing its novel proprietary ARCUS platform to develop in vivo gene editing therapies for diseases with high unmet need,
Advanced software tool supports consistent, objective evaluation of lumbar spine MRI scans MSKai, an advanced image identification and post-processing software platform for spine imaging, has
Fresenius Kabi, an operating company of Fresenius, and Formycon AG, announced that the U.S. Food and Drug Administration (FDA) designated Otulfi (ustekinumab-aauz) as an interchangeable
Women can now collect their own sample from the privacy of home, no speculum required, and mail it to a certified lab to be tested
Validic, a leader in healthcare technology innovation, announced that its full suite of Intelligent Digital Care Solutions and Services will soon be available in AWS
PleoPharma, a privately held company focused on finding treatments for cannabis related health issues, announced today that the U.S. Food and Drug Administration (FDA) has
Astellas Pharma, announced the U.S. Food and Drug Administration (FDA) approved expanded U.S. Prescribing information for IZERVAY for the treatment of geographic atrophy (GA) secondary
Fuel up with free Health Tech Insights
